Work

Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit?

Year: 2022

Type: article

Abstract: Lung cancer remains the leading cause of cancer death in the US, largely because most patients have advanced, incurable disease at the time of diagnosis.Lung cancer screening with low-dose computed tomography (LDCT) therefore has the potential to improve lung cancer outcomes through early detection.In 2013, the US Preventive Services Task Force (USPSTF) recommended lung cancer screening with LDCT annually for adults aged 55 to 80 years who have a smoking history of 30 packyears or more, and who currently smoke or formerly smoked but quit within the past 15 years. 1 This recommendation was primarily informed by the results of the National Lung Screening Trial, which demonstrated a 20% reduction in lung cancer mortality among participants aged 55 to 74 years, who underwent 3 rounds of annual screening with LDCT vs chest radiograph. 2 In March 2021, the USPSTF

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2022.43171

Authors: Dejana Braithwaite, Michael K. Gould

Institutions: University of Florida, UF Health Cancer Center, Kaiser Permanente Bernard J. Tyson School of Medicine

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000